THERAPEUTIC FORMULATIONS AND USES THEREOF

Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are de...

Full description

Saved in:
Bibliographic Details
Main Authors HEPLER, Douglas, DEMPSEY, Gail, PAULSEN, Neil, KELLY, Michael, JOHNSON, Roland, CLAYTON, Bert, DANIEL, Michael
Format Patent
LanguageEnglish
French
Published 06.05.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described. L'invention concerne des compositions pharmaceutiquement acceptables contenant un inhibiteur sélectif de la cyclo-oxygénase-2 (COX-2) (coxib) et éventuellement de la buprénorphine. En particulier, l'invention concerne des compositions contenant un coxib formulé pour une administration orale, topique ou sous-cutanée pour traiter la douleur ou l'inflammation.
AbstractList Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described. L'invention concerne des compositions pharmaceutiquement acceptables contenant un inhibiteur sélectif de la cyclo-oxygénase-2 (COX-2) (coxib) et éventuellement de la buprénorphine. En particulier, l'invention concerne des compositions contenant un coxib formulé pour une administration orale, topique ou sous-cutanée pour traiter la douleur ou l'inflammation.
Author DANIEL, Michael
HEPLER, Douglas
DEMPSEY, Gail
JOHNSON, Roland
KELLY, Michael
CLAYTON, Bert
PAULSEN, Neil
Author_xml – fullname: HEPLER, Douglas
– fullname: DEMPSEY, Gail
– fullname: PAULSEN, Neil
– fullname: KELLY, Michael
– fullname: JOHNSON, Roland
– fullname: CLAYTON, Bert
– fullname: DANIEL, Michael
BookMark eNrjYmDJy89L5WTQDPFwDXIMcA0N8XRWcPMP8g31cQzx9PcLVnD0c1EIDXYNVgCpcPV342FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGhgYW5gbmJo6GxsSpAgDKqic9
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate FORMULATIONS THÉRAPEUTIQUES ET LEURS UTILISATIONS
ExternalDocumentID WO2021087074A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2021087074A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2021087074A13
Notes Application Number: WO2020US57899
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210506&DB=EPODOC&CC=WO&NR=2021087074A1
ParticipantIDs epo_espacenet_WO2021087074A1
PublicationCentury 2000
PublicationDate 20210506
PublicationDateYYYYMMDD 2021-05-06
PublicationDate_xml – month: 05
  year: 2021
  text: 20210506
  day: 06
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies PIEDMONT ANIMAL HEALTH INC
RelatedCompanies_xml – name: PIEDMONT ANIMAL HEALTH INC
Score 3.3371558
Snippet Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title THERAPEUTIC FORMULATIONS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210506&DB=EPODOC&locale=&CC=WO&NR=2021087074A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQS1U9NSU3WTkwyTdE1SU4x0E1MSTXQtLM3STFLT0kwtLUC7kX39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3DOy_mBqYqbk42boG-Lv4O6s5OwP7bWp-QRA5YNo0N3EE9pVYQQ1p0En7rmFOoH0pBciVipsgA1sA0Ly8EiEGptQ8YQZOZ9jda8IMHL7QKW8gE5r7ikUYNEM8XIMcA1xDQzydFYC9N99QH8guYAVHPxeFUGDJqABS4ervJsqg7OYa4uyhC7QzHu7F-HB_ZAcaizGwADv_qRIMCmnGqRbmaUkGqakWxsB6JAXYvbBINE41tDSxNE8ysjCUZJDBZ5IUfmlpBi4QF7yAz0yGgaWkqDRVFljJliTJgcMGAMeFe9U
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWl4ENxXb_ShyFd2tJpvxit7m20awqCzOEq_vteuk73tLeQC5cPcnf5JXcXgPuMn1NLxqR5LueSyoqBlBWZKhFTL1VWlppJeDRyEOpeqj5PtWkLPjaxMHWe0J86OSJK1Bzlvar19fL_EsuufStXj_k7Vn0-ucnQFht0jPhF6-uiPRo6cWRHVKQUcZsYTtY03JuGaiFW2jN4fl5-eHod8biU5bZRcY9gP0Z-i-oYWmzRhQ7d_L3WhYOgefLGYiN9qxN4SDxnYsVOmoypgOgtSP11FLBghbaQomYUeAsnck_hznUS6knY5-xvirO3aHuAyhm0EfyzcxBKhRGjzPuMEQXtSIHwgmQKk03VNPIBkS-gt4vT5W7yLXS8JPBn_jh8uYJDTqqd-fQetKuvb3aNBrfKb-p1-gW6RH7C
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THERAPEUTIC+FORMULATIONS+AND+USES+THEREOF&rft.inventor=HEPLER%2C+Douglas&rft.inventor=DEMPSEY%2C+Gail&rft.inventor=PAULSEN%2C+Neil&rft.inventor=KELLY%2C+Michael&rft.inventor=JOHNSON%2C+Roland&rft.inventor=CLAYTON%2C+Bert&rft.inventor=DANIEL%2C+Michael&rft.date=2021-05-06&rft.externalDBID=A1&rft.externalDocID=WO2021087074A1